CSL Parkville office)

Investor Relations

A Biotech Leader Driven by Our Promise

CSL is a global biotech leader. We conduct business in over 60 countries, with major facilities in Australia, Germany, Switzerland, the United Kingdom and the United States. With an unwavering focus on our promise to patients – to deliver life-saving and life-improving therapies that help many thousands of people live full lives – it is our dedicated management and employees that drive our performance.

Shareholder information meeting

Shareholder Information

Group looking at their dividend information

Dividends

Contact Investor Relations

Mark Dehring

Head of Investor Relations
45 Poplar Road, Parkville
Victoria 3052
Australia
Phone: +61 3 9389 3407

Bernard Ronchi

Senior Manager, Investor Relations
45 Poplar Road, Parkville
Victoria 3052
Australia
Phone: +61 3 9389 3470